Form 4: IRIX Insider Purchases 1,000 Shares at ~$1.28

Rhea-AI Filing Summary

Romeo R. Dizon, Chief Financial Officer of IRIDEX Corp (IRIX), reported purchases of common stock on 08/27/2025. The filing shows three open-market acquisitions totaling 1,000 shares: 500 shares at $1.28, 250 shares at $1.2746, and 250 shares at $1.2964. Each line reports the resulting beneficial ownership rising sequentially to 50,245; 50,495; and 50,745 shares, and ownership is reported as direct. No derivative transactions were reported. The Form 4 is signed by an attorney-in-fact on behalf of the reporting person.

Positive

• Transparent disclosure of three open-market purchases with exact share counts and prices
• Direct ownership reported, ending at 50,745 shares, clarifying insider stake
• No derivatives reported, simplifying assessment of insider exposure

Negative

• None.

Insights

Financial Analyst

TL;DR: Insider purchased 1,000 IRIX shares in small separate trades, increasing direct holdings to 50,745 shares.

The reported transactions are routine open-market purchases by the company's CFO totaling 1,000 shares executed on 08/27/2025 at prices between $1.2746 and $1.2964. The filing lists incremental beneficial ownership amounts after each trade, ending at 50,745 shares held directly. There are no derivative instruments disclosed and no amendments noted. From a financial analysis perspective, these are small, transparent purchases recorded under Section 16 reporting rules and provide limited new information about company operations or financial performance.

Corporate Governance / Compliance Specialist

TL;DR: Form 4 properly discloses direct insider purchases and is signed by an authorized attorney-in-fact.

The Form 4 identifies the reporting person, relationship as Chief Financial Officer, and discloses three purchase transactions on 08/27/2025 with exact share counts and prices, satisfying disclosure requirements. Ownership is explicitly listed as direct. The signature block shows the form was executed by an attorney-in-fact, which is permitted when properly authorized. There are no indications of Rule 10b5-1 plan use or derivative activity. Compliance-wise, the filing appears complete for the disclosed transactions.

Insider Trade Summary

Net Buyer: 1,000 shares

Net Buy 3 txns

Insider Dizon Romeo R

Role Chief Financial Officer

Bought 1,000 shs ($1K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	500	$1.28	$640.00
Purchase	Common Stock	250	$1.2746	$318.65
Purchase	Common Stock	250	$1.2964	$324.10

Holdings After Transaction: Common Stock — 50,745 shares (Direct)

FAQ

What trades did IRIX CFO Romeo R. Dizon report on Form 4?

He reported three purchases on 08/27/2025 totaling 1,000 shares: 500 at $1.28, 250 at $1.2746, and 250 at $1.2964.

What was Romeo Dizon's beneficial ownership after these transactions?

The filing shows sequential beneficial ownership amounts of 50,245, 50,495, and 50,745 shares following each reported purchase.

Were any derivative securities reported by the insider in this Form 4?

No. Table II for derivative securities contains no reported transactions.

Who signed the Form 4 for Romeo R. Dizon?

The Form 4 was signed by Nilo De Castro, Attorney-in-fact on behalf of Romeo R. Dizon on 08/28/2025.

Do the transactions indicate use of a 10b5-1 trading plan?

The filing does not indicate that the trades were made pursuant to a Rule 10b5-1 plan; no box or instruction identifying such a plan is checked in the provided content.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 08/27/2025 - 08:56 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dizon Romeo R

(Last) (First) (Middle)

1212 TERRA BELLA AVENUE

(Street)

MOUNTAIN VIEW CA 94043

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
IRIDEX CORP [ IRIX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/27/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/27/2025		P		500	A	$1.28	50,245	D
Common Stock	08/27/2025		P		250	A	$1.2746	50,495	D
Common Stock	08/27/2025		P		250	A	$1.2964	50,745	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Nilo De Castro, Attorney-in-fact for Romeo R. Dizon	08/28/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.